Our partners A management consulting firm for high growth industries


Thomas A. Collet

PARTNER - Boston

Thomas Collet is Partner at CEPTON’s Boston office.

A co-founder of many start-ups, Thomas’ focus is on building new businesses and growing existing businesses through the development and commercialization of new products, technologies, and services in the life science and medical industries, with emphasis on the North American and European markets.

Thomas is a co-founder, President and CEO of Phrixus Pharmaceuticals, Inc. Prior to Phrixus, Thomas served as President and CEO of four early-stage life science companies which he was instrumental in creating, building, and financing. Previously, he was a general partner at Tullis-Dickerson (TD), where he helped manage a $40 million seed and early stage fund. Prior to his tenure at TD, Thomas was VP, Business Development at Monsanto, where he helped start Integrated Protein Technologies, the Company’s internal venture for the production of pharmaceutical proteins in green plants. Thomas started his career with McKinsey & Company, Inc, where he advised clients in Europe and the US on strategy and operations in the healthcare and pharmaceutical industries. At McKinsey, his clients were primarily small, technology-focused business units of Fortune 100 companies.
Cumulatively, Thomas’s four companies have raised more than $30 million in seed and early-stage capital since 2001 from venture capitalists, pharmaceutical companies, individual investors, and government programs. They and gathered three exits.

CEPTON Strategies news

Here are all the reports and analysis we published along with the press articles about us

CEPTON is the author of many publications in the field of healthcare and pharmaceuticals and our partners are often interviewed by the specialized press.

Orphan drugs: a lasting success story

Posted on 18.03.2020 by Marine Mousseaux

See more

Cepton amongst the leading healthcare and pharma consulting firms according to the magazine "Les décideurs"

Posted on 04.02.2020 by Marine Mousseaux

See more

AI in drug discovery: will tomorrow’s New Molecule Entities be discovered by robots?

Posted on 02.09.2019 by Maxime Huerre

See more

The growing role of Real-World Evidence, from regulatory strategies to patient management

Posted on 30.04.2019 by Maxime Huerre

See more

Forever young: how the cult of beauty created a $11bn medical aesthetics market

Posted on 22.01.2019 by Maxime Huerre

See more

CEPTON ranked among the top consulting firms in Healthcare and Pharma Industry by the magazine "Les Décideurs"

Posted on 21.01.2019 by Maxime Huerre

See more

Contact us

You have a question, an issue you would like to share with us

Feel free to contact us to arrange a meeting or a teleconference, using the form below.

You would like to apply for a job with us

We are always happy to welcome new profiles in our teams, please fill the following form to apply for a job in CEPTON.